TickerFacts.

GeneDx Holdings Corp. (WGS): Long-Term Debt

Annual figures by period end, from SEC filings.

$54.54M
As of 2025-12-31
$100.00M
As of 2026-06-30
+70.5%
3-year compound annual growth
$56.25M2021-12-31: $11.00M2022-12-31: $11.00M2023-12-31: $56.25M2024-12-31: $55.75M2025-12-31: $54.54M$54.54M
2021-12-31 Long-Term Debt (USD) 2025-12-31
Period endedLong-Term DebtChange YoYSource filing
2025-12-31$54.54M-2.2%2026-02-23, Balance as of period end
2024-12-31$55.75M-0.9%2025-02-20, Balance as of period end
2023-12-31$56.25M+411.4%2024-02-23, Balance as of period end
2022-12-31$11.00M0.0%2023-03-16, Balance as of period end
2021-12-31$11.00Mn/a2022-03-14, Balance as of period end

Long-Term Debt at similar companies

Companies with the same SEC industry code (Services-Health Services), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedLong-Term DebtChange YoY
GeneDx Holdings Corp. (WGS)2025-12-31$54.54M-2.2%
DocGo Inc. (DCGO)2025-12-31$235.6Kn/m
Omada Health, Inc. (OMDA)2025-12-31$0-100.0%
Pennant Group, Inc. (PNTG)2025-12-31$168.84Mn/a
InnovAge Holding Corp. (INNV)2026-06-30$48.81M-18.6%
LifeStance Health Group, Inc. (LFST)2025-12-31$282.75M-2.5%
P3 Health Partners Inc. (PIII)2025-12-31$228.37M+109.7%
Vsee Health, Inc. (VSEE)2025-12-31$2.74M+41.8%

Compare WGS, DCGO, OMDA, PNTG side by side · Screen every company in Services-Health Services ↗